BAUSCH + LOMB CORP (BLCO.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:BLCO - CA0717051076 - Common Stock
23.45 CAD
-0.05 (-0.21%)
Overall BLCO gets a fundamental rating of 4 out of 10. We evaluated BLCO against 15 industry peers in the Health Care Equipment & Supplies industry. BLCO has a medium profitability rating, but doesn't score so well on its financial health evaluation. BLCO has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
BLCO had positive earnings in the past year.
In the past year BLCO had a positive cash flow from operations.
In multiple years BLCO reported negative net income over the last 5 years.
BLCO had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
BLCO has a Return On Assets of -2.21%. This is amongst the best in the industry. BLCO outperforms 100.00% of its industry peers.
BLCO's Return On Equity of -4.74% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
With an excellent Return On Invested Capital value of 0.70%, BLCO belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BLCO is in line with the industry average of 0.70%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROIC | 0.7% |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
1.3 Margins
BLCO's Operating Margin of 2.33% is amongst the best of the industry. BLCO outperforms 100.00% of its industry peers.
In the last couple of years the Operating Margin of BLCO has declined.
The Gross Margin of BLCO (59.45%) is better than 73.33% of its industry peers.
In the last couple of years the Gross Margin of BLCO has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.33% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% |
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BLCO is destroying value.
Compared to 1 year ago, BLCO has more shares outstanding
BLCO has more shares outstanding than it did 5 years ago.
BLCO has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.87, we must say that BLCO is in the distress zone and has some risk of bankruptcy.
BLCO has a Altman-Z score of 0.87. This is amongst the best in the industry. BLCO outperforms 86.67% of its industry peers.
BLCO has a Debt/Equity ratio of 0.77. This is a neutral value indicating BLCO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.77, BLCO is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.87 |
ROIC/WACC0.1
WACC7.3%
2.3 Liquidity
A Current Ratio of 1.51 indicates that BLCO should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.51, BLCO belongs to the best of the industry, outperforming 86.67% of the companies in the same industry.
A Quick Ratio of 0.98 indicates that BLCO may have some problems paying its short term obligations.
BLCO's Quick ratio of 0.98 is fine compared to the rest of the industry. BLCO outperforms 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 |
3. Growth
3.1 Past
The earnings per share for BLCO have decreased strongly by -29.51% in the last year.
BLCO shows a small growth in Revenue. In the last year, the Revenue has grown by 6.23%.
The Revenue has been growing slightly by 4.87% on average over the past years.
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
3.2 Future
Based on estimates for the next years, BLCO will show a very strong growth in Earnings Per Share. The EPS will grow by 22.03% on average per year.
The Revenue is expected to grow by 4.98% on average over the next years.
EPS Next Y-10.98%
EPS Next 2Y13.37%
EPS Next 3Y20.28%
EPS Next 5Y22.03%
Revenue Next Year6.46%
Revenue Next 2Y6.13%
Revenue Next 3Y5.92%
Revenue Next 5Y4.98%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 39.75, which means the current valuation is very expensive for BLCO.
100.00% of the companies in the same industry are more expensive than BLCO, based on the Price/Earnings ratio.
BLCO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.51.
Based on the Price/Forward Earnings ratio of 21.49, the valuation of BLCO can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLCO indicates a rather cheap valuation: BLCO is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, BLCO is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.75 | ||
| Fwd PE | 21.49 |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than BLCO, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 19.68 |
4.3 Compensation for Growth
The decent profitability rating of BLCO may justify a higher PE ratio.
BLCO's earnings are expected to grow with 20.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.37%
EPS Next 3Y20.28%
5. Dividend
5.1 Amount
BLCO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:BLCO (12/31/2025, 7:00:00 PM)
23.45
-0.05 (-0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners11.05%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap8.31B
Revenue(TTM)4.98B
Net Income(TTM)-305.00M
Analysts72
Price Target22.67 (-3.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.13%
Min EPS beat(2)1.79%
Max EPS beat(2)8.47%
EPS beat(4)3
Avg EPS beat(4)-86.5%
Min EPS beat(4)-360.35%
Max EPS beat(4)8.47%
EPS beat(8)6
Avg EPS beat(8)-37.66%
EPS beat(12)9
Avg EPS beat(12)-24.06%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.15%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-1.38%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)-0.16%
Revenue beat(8)3
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.5%
PT rev (3m)4.63%
EPS NQ rev (1m)-1.52%
EPS NQ rev (3m)-4.39%
EPS NY rev (1m)0.68%
EPS NY rev (3m)2.3%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)-0.85%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.19%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 39.75 | ||
| Fwd PE | 21.49 | ||
| P/S | 1.22 | ||
| P/FCF | N/A | ||
| P/OCF | 35.9 | ||
| P/B | 0.94 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.68 |
EPS(TTM)0.59
EY2.52%
EPS(NY)1.09
Fwd EY4.65%
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)0.65
OCFY2.79%
SpS19.23
BVpS24.85
TBVpS-6.01
PEG (NY)N/A
PEG (5Y)N/A
Graham Number18.16
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.21% | ||
| ROE | -4.74% | ||
| ROCE | 0.97% | ||
| ROIC | 0.7% | ||
| ROICexc | 0.72% | ||
| ROICexgc | 2.29% | ||
| OM | 2.33% | ||
| PM (TTM) | N/A | ||
| GM | 59.45% | ||
| FCFM | N/A |
ROA(3y)-1.41%
ROA(5y)-0.54%
ROE(3y)-2.87%
ROE(5y)-1.37%
ROIC(3y)1.45%
ROIC(5y)1.75%
ROICexc(3y)1.5%
ROICexc(5y)1.8%
ROICexgc(3y)4.98%
ROICexgc(5y)6.16%
ROCE(3y)2.02%
ROCE(5y)2.43%
ROICexgc growth 3Y-21.86%
ROICexgc growth 5Y-17.06%
ROICexc growth 3Y-20.45%
ROICexc growth 5Y-15.79%
OM growth 3Y-22.07%
OM growth 5Y-17.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.06%
GM growth 5Y-1.25%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 9.05 | ||
| Cap/Depr | 85.28% | ||
| Cap/Sales | 7.34% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 31.07% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.51 | ||
| Quick Ratio | 0.98 | ||
| Altman-Z | 0.87 |
F-Score4
WACC7.3%
ROIC/WACC0.1
Cap/Depr(3y)53.43%
Cap/Depr(5y)52.81%
Cap/Sales(3y)5.03%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y-10.98%
EPS Next 2Y13.37%
EPS Next 3Y20.28%
EPS Next 5Y22.03%
Revenue 1Y (TTM)6.23%
Revenue growth 3Y8.36%
Revenue growth 5Y4.87%
Sales Q2Q%7.11%
Revenue Next Year6.46%
Revenue Next 2Y6.13%
Revenue Next 3Y5.92%
Revenue Next 5Y4.98%
EBIT growth 1Y-38.95%
EBIT growth 3Y-15.55%
EBIT growth 5Y-13.93%
EBIT Next Year46.23%
EBIT Next 3Y23.44%
EBIT Next 5Y15.82%
FCF growth 1Y-880%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.07%
OCF growth 3Y-35.71%
OCF growth 5Y-21.91%
BAUSCH + LOMB CORP / BLCO.CA FAQ
What is the fundamental rating for BLCO stock?
ChartMill assigns a fundamental rating of 4 / 10 to BLCO.CA.
What is the valuation status of BAUSCH + LOMB CORP (BLCO.CA) stock?
ChartMill assigns a valuation rating of 4 / 10 to BAUSCH + LOMB CORP (BLCO.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for BAUSCH + LOMB CORP?
BAUSCH + LOMB CORP (BLCO.CA) has a profitability rating of 6 / 10.
What is the financial health of BAUSCH + LOMB CORP (BLCO.CA) stock?
The financial health rating of BAUSCH + LOMB CORP (BLCO.CA) is 3 / 10.